From the 2022 Joint Annual Meeting (recorded 6/28/2022)
Presented by Elissa Passiment, EdM, MT(ASCP) and Andrea Pitkus, PhD, MLS(ASCP)CM

Learn about criteria to identify acute kidney injury (AKI) and chronic kidney disease (CKD), including biomarkers and their historic use in different equations for calculating estimated Glomerular Filtration Rate (eGFR). Impacts of implementing the 2021 eGFR equation will be discussed, including informatics and patient safety aspects.

LEARNING OBJECTIVES
At the conclusion of this presentation, participants will be able to:

• Discuss the challenges of diagnosing acute kidney injury (AKI) and chronic kidney disease (CKD)
• Evaluate the tests and calculations for kidney disease for efficacy
• Describe at least two patient safety concerns which may occur with the test data

CE ACCREDITATION
ASCLS is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. One (1) P.A.C.E. ® contact hour and one (1) Florida credit hour in the area of ADM, C/U (Chemistry) will be awarded to participants. ASCLS P.A.C.E.® is accepted by the ASCP/ASCLS/AGT Board of Certification and all states, including Florida and California, as an approved provider of continuing education for recertification and licensure. ASCLS is an approved provider with CE Broker for Florida licensees.

LEVEL OF INSTRUCTION
This Intermediate-level program is appropriate for laboratory professionals working in clinical, public health and academic settings.